NEW YORK, Oct. 7, 2020 /PRNewswire/ -- The global single-use bioreactors market is projected to reach USD 3.9 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 18.0% during the forecast period. Increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption, the growing biologics market, technological advancements in SUBs, and increasing Biopharmaceutical R&D are factors driving the growth of this market.

Read the full report: https://www.reportlinker.com/p04208113/?utm_source=PRN

By type, the stirred-tank SUBs segment accounted for the largest share of the single-use bioreactors market The single-use bioreactors market is categorized into major four types, wave-induced SUBs, stirred-tank SUBs, bubble-column SUBs, and other bioreactors.The stirred-tank SUBs segment dominated the single-use bioreactors market in 2019.

The large share of this segment can be attributed to factors such as the high preference for stirred-tank SUBs in the cultivation of aerobic microbial cultures due to its abilty to provide greater oxygen transfer and reduced engineering challenges such as heat removal, mass transfer, and higher agitation rates.

Asia Pacific: The fastest-growing region in the single-use bioreactors market.

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the growing biopharmaceutical industry, increasing life science research, rising investments by pharmaceutical and biotechnology companies, and the growing number of CROs and CMOs in several APAC countries contribute to its growth.

North America: the largest share of the single-use bioreactors market North America accounted for the largest share of the single-use bioreactors market. Factors such as the to the presence of an established biopharmaceutical industry and the presence of major players operating in the single-use bioreactors market in the region are the major factors driving the market growth.

Breakdown of primaries The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows: By Respondent Supply Side- 70%, Demand Side- 30% By Designation Executives- 25%, CXOs, Directors- 20%, Managers - 55% By Region North America - 50%, Europe - 20%, APAC 20%, RoW- 10%

The single-use bioreactors market is dominated by a few globally established players such as C Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), Merck Millipore (Germany). Other players in this market includes, Getinge (Sweden), Eppendorf AG (Germany), Parker Hannifin Corporation (US), Pierre Gurin (France), Meissner Filtration Products, Inc. (US), Solida Biotech GmbH (Germany), Satake Chemical Equipment Mfg., Ltd. (Japan), Able Corporation & Biott Corporation (Japan), ABEC, Inc. (US), Distek, Inc. (US), PBS Biotech, Inc. (US), CESCO Bioengineering Co. Ltd. (Taiwan), New Horizon Biotechnology, Inc. (US), bbi-biotech GmbH (Germany), Celltainer Biotech BV (Netherlands), Cellexus (UK), Stobbe Pharma GmbH (Switzerland), G&G Technologies, Inc. (US), CerCell A/S (Denmark), Charter Medical Ltd. (US), Solaris Biotech USA (US) and OmniBRx Biotechnologies Pvt. Ltd. (India).

Research Coverage: The report segments the single-use bioreactors market based on region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), products (Single-use bioreactor systems (up to 10L, 11100L, 101500L, 011500L, above 1500L), single-use media bags (2D bags, 3D bags, other bags), single-use filtration assemblies, and other products), type (Stirred-tank SUBs, wave-induced SUBs, bubble-column SUBs, and other SUBs), Type of Cell (Mammalian cells, bacterial cells, yeast cells, and other cells), Molecule Type (Monoclonal antibodies, vaccines, gene-modified cells, stem cells, and other molecules), application (Research & development, process development, and bioproduction), end users (Pharmaceutical & biopharmaceutical companies, CROs and CMOs, and academic & research Institutes).

The report also provides a comprehensive review of market drivers, challenges, and opportunities in the single-use bioreactors market

Key Benefits of Buying the Report: The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments.This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies.

The report also helps stakeholders understand the pulse of the single-use bioreactors market and provides them information on key market drivers, challenges, and opportunities.

Read the full report: https://www.reportlinker.com/p04208113/?utm_source=PRN

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001

SOURCE Reportlinker

http://www.reportlinker.com

Continue reading here:
The global single-use bioreactors market is projected to reach USD 3.9 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 18.0% - PRNewswire